Related Experiment Video
Updated: May 30, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially
Alberto Palazzuoli1, Claudio Ronco
1Department of Internal Medicine and Metabolic Diseases, Cardiology Section, University of Siena, Siena, Italy. palazzuoli2@unisi.it
Insights
Cardio-renal syndromes link heart failure and chronic kidney disease, worsening patient outcomes. Understanding the "vicious heart/kidney circle" is key to reducing mortality and hospitalizations.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Background:
- Heart failure (HF) and chronic kidney disease (CKD) are interconnected, contributing to cardio-renal syndromes.
- Renal impairment in HF patients is an independent risk factor for morbidity and mortality, yet often excluded from clinical trials.
- The mechanisms linking renal insufficiency to worse HF outcomes, forming a
Purpose of the Study:
- To elucidate the mechanisms underlying the adverse outcomes in patients with cardio-renal syndromes.
- To explore the
Main Methods:
- Review of existing literature on cardio-renal syndromes.
- Analysis of pathophysiological pathways linking renal and cardiac dysfunction.
Main Results:
- Renal impairment exacerbates HF outcomes through complex mechanisms, not solely hypoperfusion.
- Neurohormonal activation (sympathetic activity, renin-angiotensin-aldosterone, arginine-vasopressin) plays a crucial role.
- These pathways lead to fluid retention, vasoconstriction, and increased cardiac workload.
Conclusions:
- Targeting renal dysfunction, neurohormonal activation, and renal blood flow may improve outcomes in cardio-renal syndrome.
- Interventions aimed at ameliorating renal function and reducing cardiac workload are crucial.
- Further research is needed to fully understand and manage cardio-renal interactions.
Abstract:
Heart failure may lead to acute kidney injury and vice versa. Chronic kidney disease may affect the clinical outcome in terms of cardiovascular morbidity and mortality while chronic heart failure may cause CKD. All these disorders contribute to the composite definition of cardio-renal syndromes. Renal impairment in HF patients has been increasingly recognized as an independent risk factor for morbidity and mortality; however, the most important clinical trials in HF tend to exclude patients with significant renal dysfunction. The mechanisms whereby renal insufficiency worsens the outcome in HF are not known, and several pathways could contribute to the "vicious heart/kidney circle." Traditionally, renal impairment has been attributed to the renal hypoperfusion due to reduced cardiac output and decreased systemic pressure. The hypovolemia leads to sympathetic activity, increased renin-angiotensin-aldosterone pathways and arginine-vasopressin release. All these mechanisms cause fluid and sodium retention, peripheral vasoconstriction and an increased congestion as well as cardiac workload. Therapy addressed to improve renal dysfunction, reduce neurohormonal activation and ameliorate renal blood flow could lead to a reduction in mortality and hospitalization in patients with cardio-renal syndrome.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy